Schonfeld Strategic Advisors LLC
Position in SNDX — Syndax Pharmaceuticals Inc
CIK 1665241
NEW YORK, NY
Position in SNDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,174,633
-$913,590 QoQ
Shares Held
236,717
-9.2% QoQ
Ownership
0.265%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#69
of 242 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. SNDX ranks #23 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
697,586 | $66,096,273 | |
| 2 | AGIO |
Agios Pharmaceuticals, Inc.
|
520,083 | $19,300,280 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
77,272 | $18,620,233 | |
| 4 | VRDN |
Viridian Therapeutics, Inc.\DE
|
793,508 | $14,576,741 | |
| 5 | MBX |
MBX Biosciences, Inc.
|
248,670 | $13,726,584 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
227,330 | $13,721,638 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
147,425 | $12,025,457 | |
| 8 | INSM |
INSMED Inc
|
104,378 | $11,128,782 |
All Filings in SNDX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,174,633 | 236,717 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,088,223 | 260,626 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $275,231 | 13,100 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,032,712 | 132,123 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,479,327 | 264,744 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $569,962 | 46,395 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $273,085 | 20,657 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,608,662 | 187,463 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,355,784 | 260,876 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $18,698,327 | 785,644 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $10,188,574 | 471,475 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,171,356 | 218,413 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,993,207 | 238,567 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,116,593 | 147,566 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $231,595 | 9,100 | Shares | Sole | 2023-02-14 | |
| 2021-12-31 | $269,247 | 12,300 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,444,716 | 75,600 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $2,050,115 | 119,401 | Shares | Sole | 2021-11-16 | |
| 2021-03-31 | $2,783,864 | 124,502 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,494,571 | 157,130 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $307,244 | 20,816 | Shares | Sole | 2020-11-19 | |
| No filing history on record for this holder in this stock. | ||||||